Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs. Standard of Care in Second-Line Treatment for Relapsed/Refractory Large B-Cell Lymphoma in Spain
- Martín García-Sancho, A.
- Presa, M.
- Pardo, C.
- Martín-Escudero, V.
- Oyagüez, I.
- Ortiz-Maldonado, V.
Revue:
Cancers
ISSN: 2072-6694
Année de publication: 2024
Volumen: 16
Número: 13
Type: Article